Channing J. Der, PhD

EDUCATION

1981-1985	Harvard Medical School (Pathology) and Dana-Farber Cancer Institute (Postdoctoral Fellowship)
1981 Ph.D.	University of California, Irvine (Microbiology
1975 B.A.	University of California, Los Angeles (Biology)

PROFESSIONAL EXPERIENCE

2012 - 2013	President, Cancer Biology Training Consortium
2010 - 2013	Board of Directors, Cancer Biology Training Consortium
2010	Consultant, Bristol-Myers Squibb
2010	Consultant, AstraZeneca
2010	Consultant, Sanofi-Aventis
2010 - 2012	Chair, Pancreatic Cancer Action Network-AACR Innovative Grants Scientific Review Committee
2010 - 2011	AACR Program Committee
2009 - present	Editorial Board, Bioscience Reports
2009 - present	Editorial Board, Small GTPases
2009 - present	Editorial Board, Genes & Cancer
2008	Senior Academic Visitor of Wolfson College, Cambridge, UK
2008 - present	Scientific Advisory Board, Lustgarten Foundation for Pancreatic Cancer Research
2008 - present	Consultant, Millipore
2007 - 2011	Reviewer, Italian Association Cancer Research
2007 - 2008	AACR Program Committee
2007 - 2008	Member, Children’s Tumor Foundation, Drug Discovery Initiative Panel
2007	Member, AACR Grants Subcommittee for Pancreatic Cancer Research Fellowship
2006 - 2009	Member, DOD Neurofibromatosis Research Program Integration Panel
2006 - present	Editorial Board, Journal Molecular Signaling
2004 - 2007	AACR Laboratory Research Awards Selection Committee
2005 - present	Member, Cancer Biology Training Consortium
2003	Consultant, Chemicon
2003	Consultant, Upstate Biotechnology
2003	Consultant, Odyssey Thera
2002	Consultant, PPD Discovery
2001- present	Member, Faculty of 1000
2001	External Reviewer, Wake Forest Cancer Center Program
2000 - 2002	Associate Editor, Cancer Research
2000 - present	Editorial Board, Cancer Letters
2000 - present	Consultant, Tularik
1998 - present	Director, NIH Cancer Cell Biology Training Grant
1998 - present	Board of Advisors, Children’s Tumor Foundation
1998 - present	Member, Curriculum in Toxicology, UNC-Chapel Hill
1998	Consultant, Schering-Plogh
1997	Consultant, Dupont-Merck
1996 - 1997	Consultant, Biomeasure
1996	Consultant, Merck
1995 -1996	Consultant, Parke-Davis
1995 - present	Professor, Department of Pharmacology, Member, UNC Lineberger Comprehensive Cancer Center and Member, Curriculum in Genetics and Molecular Biology, University of North Carolina at Chapel Hill
1992-1995	Associate Professor, Department of Pharmacology, Member, UNC Lineberger Comprehensive Cancer Center and Member, Curriculum in Genetics and Molecular Biology, University of North Carolina at Chapel Hill
1992-1996	Member, NIH Pathology B Study Section
1992-1994	Consultant, Bristol-Myers Squibb
1992-1993	Consultant, Dupont Merck Pharmaceuticals
1991-1993	Consultant, Eisai Research Institute
1990-present	Consultant, Special Review Committee, NCI
1989-1991	Ad Hoc Member, NIH Pathology B Study Section
1989-1992	Staff Scientist, The Burnham Institute
1985-1989	Assistant Staff Scientist, The Burnham Institute
1981-1985	Postdoctoral Fellow, Harvard Medical School and the Dana-Farber Cancer Institute

HONORS AND AWARDS

Recipient, Lauds & Laurels, Distinguished Alumni Award, University of California, Irvine (2012) Keynote Speaker, Ras-Like GTPases and Tumor Suppressors: Are We Ready For Translation? Tel Aviv, Israel (2012)

Keynote Speaker, Fayetteville State University-SPIRE Cancer Symposium (2011)

Keynote Speaker, Mayo Clinic Graduate Student Retreat (2011)

Recipient, Hyman L. Battle Distinguished Cancer Research Award (2011)

Keynote Speaker, 16th International AEK Cancer Congress, Düsseldorf, Germany (2011)

Keynote Speaker, International Symposium on RASSF Family of Tumor Suppressor Proteins, Calgary, Canada (2009)

Keynote Speaker, Annual Cancer Center Retreat, Wake Forest University (2009)

Organizer, Cold Spring Harbor/Banbury Lustgarten KRAS Think Tank, Cold Spring Harbor, NY (2008)

Keynote Speaker, Annual Meeting of the Pharmaceutical Society of Korea, Jeju Island, Korea (2008)

Co-Organizer, Lustgarten/AACR Pancreatic Cancer Meeting, Chapel Hill, NC (2006)

Sarah Graham Kenan Distinguished Professorship (2006)

Keynote Speaker, FASEB Summer Research Conference, Saxton River, VT (2006)

Co-Chair, CNIO Cancer Conference, Madrid, Spain (2003)

Co-Organizer, Annual Oncogene Meeting, Frederick, MD (2003)

Keynote Speaker, MIT/Neurofibromatosis Foundation Consortium Meeting, Cambridge, MA (1999)

Organizer, NIEHS Symposium on Small GTPases and Cancer, Research Triangle Park, NC (1998)

Keynote Speaker, First Mark Roth Memorial Lecture, Ann Arbor, MI (1997)

Co-Chair, FASEB Summer Research Conference, Saxton River, VT (1991)

Recipient, American Cancer Society Faculty Research Award (1990-1995)

Recipient, NRSA Postdoctoral Fellowship (1985-86)

Recipient, Damon Runyon-Walter Winchell Postdoctoral Fellowship (1983-85)